Take Care Before Jumping Onto Root, Inc. (NASDAQ:ROOT) Even Though It's 36% Cheaper

Root, Inc. (NASDAQ:ROOT) shares have had a horrible month, losing 36% after a relatively good period beforehand. Nonetheless, the last 30 days have barely left a scratch on the stock's annual performance, which is up a whopping 446%.

Although its price has dipped substantially, there still wouldn't be many who think Root's price-to-sales (or "P/S") ratio of 0.9x is worth a mention when the median P/S in the United States' Insurance industry is similar at about 1x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.

View our latest analysis for Root

ps-multiple-vs-industry
NasdaqGS:ROOT Price to Sales Ratio vs Industry August 19th 2024
Advertisement

What Does Root's P/S Mean For Shareholders?

Root certainly has been doing a good job lately as it's been growing revenue more than most other companies. One possibility is that the P/S ratio is moderate because investors think this strong revenue performance might be about to tail off. If the company manages to stay the course, then investors should be rewarded with a share price that matches its revenue figures.

Keen to find out how analysts think Root's future stacks up against the industry? In that case, our free report is a great place to start.

Is There Some Revenue Growth Forecasted For Root?

In order to justify its P/S ratio, Root would need to produce growth that's similar to the industry.

Taking a look back first, we see that the company grew revenue by an impressive 195% last year. Pleasingly, revenue has also lifted 229% in aggregate from three years ago, thanks to the last 12 months of growth. So we can start by confirming that the company has done a great job of growing revenue over that time.

Turning to the outlook, the next three years should generate growth of 21% per year as estimated by the eight analysts watching the company. With the industry only predicted to deliver 3.7% per year, the company is positioned for a stronger revenue result.

With this in consideration, we find it intriguing that Root's P/S is closely matching its industry peers. It may be that most investors aren't convinced the company can achieve future growth expectations.

The Bottom Line On Root's P/S

With its share price dropping off a cliff, the P/S for Root looks to be in line with the rest of the Insurance industry. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

Looking at Root's analyst forecasts revealed that its superior revenue outlook isn't giving the boost to its P/S that we would've expected. There could be some risks that the market is pricing in, which is preventing the P/S ratio from matching the positive outlook. This uncertainty seems to be reflected in the share price which, while stable, could be higher given the revenue forecasts.

You always need to take note of risks, for example - Root has 3 warning signs we think you should be aware of.

If these risks are making you reconsider your opinion on Root, explore our interactive list of high quality stocks to get an idea of what else is out there.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:ROOT

Root

Provides insurance products and services in the United States.

Excellent balance sheet with questionable track record.

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1259.6% undervalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
FU
VRT logo
FundamentalFlow on Vertiv Holdings Co ·

The Short and Long Term Compounder of Liquid Cooling industry.

Fair Value:US$45040.0% undervalued
4 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
JO
John_Eric
SPXC logo
John_Eric on SPX Technologies ·

I Fell in Love With a Data-Center Cooling Stock. Then I Opened the Filings.

Fair Value:US$2034.6% overvalued
5 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
TR
tripledub
GQG logo
tripledub on GQG Partners ·

The Cheap Genius Problem

Fair Value:AU$2.4541.2% undervalued
13 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative

Updated Narratives

ES
LAGENDA logo
Ester on Lagenda Properties Berhad ·

Lagenda Properties 录得创纪录销售额与收入,推动盈利能见度提升

Fair Value:RM 2.543.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
STLR logo
RockeTeller on STLLR Gold ·

STLLR Gold, Eric Sprott + Agnico Backed: Massive Canadian Gold Developer at Junior Prices

Fair Value:CA$102.2298.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
PE
RYTM logo
peter_4mgsy on Rhythm Pharmaceuticals ·

High-Growth Emerging Commercial Stage Biotech

Fair Value:US$13413.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
289 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.5% overvalued
153 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0941.5% undervalued
174 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative